(Q35015882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Christos I Sinapis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Angelos I Sinapis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Dimitrios I Sinapis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

George D Agrogiannis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Alkistis Pantopoulou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Stamatis E Theocharis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Stefanos Baltatzis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Efstratios Patsouris

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Despoina Perrea

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

24 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Clinical Ophthalmology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

697-704

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

2 February 2020

copyright license

start time

1 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Subretinal bevacizumab detection after intravitreous injection in rabbits

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Pharmacokinetics of intravitreal ranibizumab (Lucentis).

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Clearance of intravitreal moxifloxacin

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Pharmacokinetics and safety of intravitreally delivered etanercept

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104800

Clearance of triamcinolone from vitreous

25 October 2018

1 reference

12 December 2020

Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro

1 reference

12 December 2020

[Intravitreal bevacizumab for neovascular age-related macular degeneration]

1 reference

12 December 2020

[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]

1 reference

12 December 2020

Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes

1 reference

12 December 2020

Pharmacokinetics of intravitreal bevacizumab (Avastin)

1 reference

12 December 2020

Identifiers

DOI

10.2147/OPTH.S19555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21629577%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

PubMed publication ID

21629577

1 reference